Rethinking chronic pain relief
An FDA panel recommends sweeping restrictions on a widely used over the counter painkiller, acetamenophin, and eliminating prescription drugs such as Vicodin and Percocet. How will these limitations reframe the way doctors treat chronic pain and prevent addiction?
- Roger Chou: is a doctor of internal medicine, Associate Professor of Medicine at Oregon Health & Science University and Director of Clinical Guidelines Development, the American Pain Society.
- Lynn Webster: is medical director of Lifetree Clinical Research and Pain clinic. He is also a doctor of anesthesiology, pain medicine, and addiction medicine.